Kyoto University Innovation Capital Co., Ltd.

VC · Kyoto (Japan)

VC

Seed

Series A

Sign up free to access full profile and submit your pitch.

About

Kyoto University Innovation Capital Co., Ltd. is the venture investment arm of Kyoto University specializing in seed to early stage investments. It seeks to invest in ventures that aim to commercialize research outcomes derived from Japanese national universities including Kyoto University. It was founded on December 22, 2014 and is based in Kyoto, Japan.

Investment Criteria

Other investors that have backed the same portfolio companies as Kyoto University Innovation Capital Co., Ltd.. Expand any entry to see the shared portfolio companies.

• Mitsubishi UFJ Capital

  23 shared

  Shared portfolio companies

  • Ace RNA Technologies Inc.
  • Algal Bio Co., Ltd.
  • Drawbridge Health, Inc.
  • Enecoat Technologies Co., Ltd.
  • GRA&GREEN Inc.
  • KinoPharma, Inc.
  • Kyoto Fusioneering Ltd.
  • Kyulux, Inc.
  • LegalOn Technologies, Inc.
  • Link Therapeutics Inc.
  • Luxonus Inc.
  • OOYOO Ltd.
  • Perseus Proteomics Inc.
  • Phytolipid Technologies Co., Ltd.
  • RadioNano Therapeutics Inc.
  • Regcell Co., Ltd.
  • Rege Nephro Co., Ltd.
  • SAKA NO TOCHU Co., Ltd.
  • Shinobi Therapeutics, Inc.
  • Stem Cell & Device Laboratory, Inc.
  • Symbiobe Inc.
  • tiem factory Inc.
  • Toregem Bio Pharma Co., Ltd.
• Future Venture Capital

  11 shared

  Shared portfolio companies

  • AFI Corporation
  • CONNEXX SYSTEMS Corporation
  • Enecoat Technologies Co., Ltd.
  • FLOSFIA INC.
  • KinoPharma, Inc.
  • Luxonus Inc.
  • Regcell Co., Ltd.
  • SAKA NO TOCHU Co., Ltd.
  • Space Power Technologies
  • tiem factory Inc.
  • Toregem Bio Pharma Co., Ltd.
• Kyogin Lease Co., Ltd.

  9 shared

  Shared portfolio companies

  • BTB Drug Development Research Center Co.,Ltd.
  • CONNEXX SYSTEMS Corporation
  • Enecoat Technologies Co., Ltd.
  • FLOSFIA INC.
  • Kyoto Fusioneering Ltd.
  • Rege Nephro Co., Ltd.
  • Space Power Technologies
  • Toregem Bio Pharma Co., Ltd.
  • TSK Corporation
• Nippon Venture Capital

  9 shared

  Shared portfolio companies

  • Chordia Therapeutics Inc.
  • Cuorips Inc.
  • Enecoat Technologies Co., Ltd.
  • KinoPharma, Inc.
  • Kyulux, Inc.
  • Perseus Proteomics Inc.
  • Questetra, Inc.
  • Rege Nephro Co., Ltd.
  • TOKIWA-Bio Inc.
• Global Brain Corporation

  7 shared

  Shared portfolio companies

  • Enecoat Technologies Co., Ltd.
  • Kyoto Fusioneering Ltd.
  • MaRI Co. Ltd.
  • Rege Nephro Co., Ltd.
  • Rhinoflux Inc.
  • Symbiobe Inc.
  • U-MaP Co., Ltd.
• Mizuho Capital Co., Ltd.

  7 shared

  Shared portfolio companies

  • Algal Bio Co., Ltd.
  • CONNEXX SYSTEMS Corporation
  • GRA&GREEN Inc.
  • LegalOn Technologies, Inc.
  • OOYOO Ltd.
  • Perseus Proteomics Inc.
  • SAKA NO TOCHU Co., Ltd.
• Senshu Ikeda Capital Co., Ltd.

  7 shared

  Shared portfolio companies

  • CONNEXX SYSTEMS Corporation
  • Enecoat Technologies Co., Ltd.
  • HOLO BIO Co., Ltd.
  • Rege Nephro Co., Ltd.
  • SAKA NO TOCHU Co., Ltd.
  • Space Power Technologies
  • TSK Corporation
• Daiwa Corporate Investment

  6 shared

  Shared portfolio companies

  • Ace RNA Technologies Inc.
  • Kyoto Fusioneering Ltd.
  • Kyulux, Inc.
  • Lang-8, Inc.
  • Rege Nephro Co., Ltd.
  • tiem factory Inc.
• DBJ Capital

  6 shared

  Shared portfolio companies

  • Algal Bio Co., Ltd.
  • Kyoto Fusioneering Ltd.
  • Kyulux, Inc.
  • Perseus Proteomics Inc.
  • RadioNano Therapeutics Inc.
  • Restore Vision Inc.
• QB Capital, LLC

  6 shared

  Shared portfolio companies

  • Arktus Therapeutics Co., Ltd.
  • KinoPharma, Inc.
  • KOALA Tech Inc.
  • Kyulux, Inc.
  • Rege Nephro Co., Ltd.
  • Restore Vision Inc.